Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined. ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Mouse | Rat HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is not conjugated.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Mouse | Rat HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with ATTO 390.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Mouse | Rat HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with ATTO 488.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Mouse | Rat HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with ATTO 565.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Mouse | Rat HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with ATTO 594.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with ATTO 633.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with ATTO 655.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with ATTO 680.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with ATTO 700.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with Alkaline Phosphatase.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with APC.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with APC/Cy7.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with Biotin.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with Dylight 350.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with Dylight 405.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with Dylight 488.

Description: A monoclonal antibody from clone 4F3.E8 against Human | Rat | Rainbow Trout (Oncorhynchus mykiss) HSP90 (total). The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Recombinant Human HSP90 purified from E.coli. The antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:2000), IHC (1:100), ICC/IF (1:100). This MAb for HSP90 (total) is conjugated with Dylight 594.